Evolus

Recent news

• Analysts Offer Insights on Healthcare Companies: Evolus (EOLS), Parabilis Medicines, Inc. (PBLS) and Acumen Pharmaceuticals (ABOS)
  TipRanks · 2026/9/17
• Rating change
  Analysts Are Bullish on Top Healthcare Stocks: CG Oncology, Inc. (CGON), Evolus (EOLS)
  TipRanks · 2026/5/5
• Rating change
  Mizuho Securities Maintains Evolus(EOLS.US) With Buy Rating, Cuts Target Price to $19
  Market Newswire · 2025/12/2
• Rating change
  Mizuho Securities Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $19
  Market Newswire · 2026/1/10
• Rating change
  Mizuho Securities Maintains Evolus(EOLS.US) With Buy Rating, Cuts Target Price to $15
  Market Newswire · 2026/2/4
• BTIG Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $13
  Market Newswire · 2026/8/7
• Mizuho Securities Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $15
  Market Newswire · 2026/9/11
• Rating change
  Analysts Are Bullish on These Healthcare Stocks: Evolus (EOLS), Upstream Bio, Inc. (UPB)
  TipRanks · 2026/2/4
• Rating change
  A Quick Look at Today's Ratings for Evolus(EOLS.US), With a Forecast Between $13 to $15
  Market Newswire · 2026/3/4
• Rating change
  BTIG Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $18
  Market Newswire · 2025/12/31
• Rating change
  A Quick Look at Today's Ratings for Evolus(EOLS.US), With a Forecast Between $18 to $20
  Market Newswire · 2025/11/7
• Leerink Partners Maintains Evolus(EOLS.US) With Buy Rating
  Market Newswire · 2026/9/17
• Rating change
  Needham Maintains Evolus(EOLS.US) With Hold Rating
  Market Newswire · 2026/8/7
• Rating change
  Stifel Maintains Evolus(EOLS.US) With Buy Rating, Cuts Target Price to $17
  Market Newswire · 2026/1/13
• Rating change
  Stifel Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $17
  Market Newswire · 2026/8/6
• Rating change
  BTIG Maintains Evolus(EOLS.US) With Buy Rating, Cuts Target Price to $13
  Market Newswire · 2026/1/22
• H.C. Wainwright Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $13
  Market Newswire · 2026/8/25
• Rating change
  A Quick Look at Today's Ratings for Evolus(EOLS.US), With a Forecast Between $13 to $17
  Market Newswire · 2026/8/6
• Rating change
  H.C. Wainwright Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $20
  Market Newswire · 2026/1/10
• Rating change
  Mizuho Securities Maintains Evolus(EOLS.US) With Buy Rating, Raises Target Price to $20
  Market Newswire · 2025/11/6

Headlines are aggregated automatically and are not independently verified or edited by our team.